Dr Gauthier NAMUR

Spécialisations

• Médecine nucléaire (Université de Liège, 2009)

Centres d'intérêt

• Oncologie
• Pathologies neurodégénératives
• Rhumatologie

Mandats

• Maître de stage pour la médecine nucléaire

Publications

• FDG PET/CT for diagnostic arterial prosthetic graft infection: preliminary report. (2007)
• Complementary Assessment of Abdominopelvic Disorders with PET/CT and MRI. (2008)
• Is FDG-PET/CT an early indicator of the clinical response to rituximab in rheumatoid arthritis? (2008) 
• Assessment of early therapeutic response in anti-TNFα refractory rheumatoid arthritis with FDG PET/CT. (2010)
• 2-18F-Fluoro-L-tyrosine in the suspicion of recurrence of previously treated gliomas. (2011)
• Multimodality Staging of Lung Cancer. (2011)
• Increased metabolic activity highlighted by positron emission tomography/computed tomography in the wall of the dissected ascending aorta in a patient with Horton disease. (2013)
• 18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. (2013)
• Multifactorial relationship between 18F-fluoro-deoxy-glucose positron emission tomography signaling and biomechanical properties in unruptured aortic aneurysms. (2014)
• Cancer recurrence or sarcoïdosis: the essential contribution of anatomo-pathology. (2014) 
• Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer (2016)
• P. Fosse, M-J. Kaiser, G. Namur, D. de Seny, M. G. Malaise, R. Hustinx. 18F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab. European Journal of Hybrid Imaging, (2018) 2:6. DOI 10.1186/s41824-017-0022-y
• Positron Emission Tomography/Computed Tomography Predicts and Detects Complications After Endovascular Repair of Abdominal Aortic Aneurysms (2019)

Textbook

• Rheumatology, 2-Volume Set, 5th & 6th Editions. By Marc C. Hochberg, MD, MPH, Alan J. Silman, MD, Josef S. Smolen, MD, Michael E. Weinblatt, MD and Michael H. Weisman, MD
• Bone scintigraphy and positron emission tomography (Clio Ribbens & Gauthier Namur, section « Imaging techniques »)

Communications

• “Detection by 18F-FDG PET of neurological involvement in a systemic disease”, Young Nuclearist Challenge Award Belnuc (2007)
• “Is FDG-PET/CT an early indicator of the clinical response to rituximab in rheumatoid arthritis”, SNMMI New-Orleans, USA (2008) 
• "Actualités dans la prescription des examens de médecine nucléaire" et "Le diagnostic d'embolie pulmonaire par SPECT/CT ventilation-perfusion", Journée médicale du CHC (2009 et 2014)
• "Indications du PET scan dans les affections neurologiques", GLEM neurologie (2010)
• "Apport du SPECT/CT dans les pathologies ostéoarticulaires", GLEM imagerie médicale (2015)
• "La lombalgie en 2017", SMAV
• "Bon Usage du PET-CT en oncologie digestive", RIGE (2019)
• "Maladie d'Alzheimer: biomarqueurs en imagerie moléculaire et fonctionnelle" et "Actualités dans la prise en charge de l'adénocarcinome prostatique", Comité scientifique CHC
• 19th Symposium of the Belgian Society of Nuclear Médicine (2019), en collaboration avec le Dr Bénédicte Daenen:
  • "Back Pain Management for technologists"
  • "Back Pain Management: The value of CT and MRI and the added value of SPECT/CT"